Avadel Pharma gains after appeals court ruling in Lumryz case with Jazz Pharma (AVDL:NASDAQ)

Avadel Pharmaceuticals (NASDAQ:AVDL) rose 1.6% after an appeals court ruling in its dispute with Jazz Pharmaceuticals (NASDAQ:JAZZ) over narcolepsy drug Lumryz.

“We have considered the parties’ remaining arguments and find them unpersuasive,” a federal appeals court wrote in its opinion on Tuesday. “We